An epidemiological investigation of high-risk children for Respiratory Syncytial Virus infections - RWE palivizumab utilization as a RSV preventive treatment in Lazio (Italy)

07/12/2022
23/04/2024
EU PAS number:
EUPAS49568
Study
Ongoing

ENCePP Code of conduct

No
Data sources

Data source(s)

Data source(s), other

Lazio Administrative Database Italy

Data sources (types)

Administrative healthcare records (e.g., claims)
Use of a Common Data Model (CDM)

CDM mapping

No
Data quality specifications

Check conformance

Unknown

Check completeness

Unknown

Check stability

Unknown

Check logical consistency

Unknown
Data characterisation

Data characterisation conducted

No
Procedures
No information provided.